Ata uhi

In Silico Clinical Trials for Cardiovascular Disease A Finite Element and Machine Learning Approach /

This book covers in silico clinical trials of cardiovascular disease using a finite element and machine learning approach. Part I describes the fundamentals as well as the latest developments in the field: finite element modeling, system biology modeling for drug optimization, artificial intelligenc...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Kaituhi rangatōpū: SpringerLink (Online service)
Ētahi atu kaituhi: Filipović, Nenad (Editor)
Hōputu: Tāhiko īPukapuka
Reo:Ingarihi
I whakaputaina: Cham : Springer Nature Switzerland : Imprint: Springer, 2024.
Putanga:1st ed. 2024.
Ngā marau:
Cardiovascular system.
Physiology.
Machine learning.
Artificial intelligence.
Drug delivery systems.
Cardiovascular Physiology.
Machine Learning.
Artificial Intelligence.
Drug Delivery.
Urunga tuihono:https://doi.org/10.1007/978-3-031-60044-9
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-60044-9
003 DE-He213
005 20251113192608.0
007 cr nn 008mamaa
008 240728s2024 sz | s |||| 0|eng d
020 |a 9783031600449  |9 978-3-031-60044-9 
024 7 |a 10.1007/978-3-031-60044-9  |2 doi 
050 4 |a QP101-110 
072 7 |a PSA  |2 bicssc 
072 7 |a SCI056000  |2 bisacsh 
072 7 |a PSA  |2 thema 
082 0 4 |a 573.1  |2 23 
245 1 0 |a In Silico Clinical Trials for Cardiovascular Disease  |h [electronic resource] :  |b A Finite Element and Machine Learning Approach /  |c edited by Nenad Filipović. 
250 |a 1st ed. 2024. 
264 1 |a Cham :  |b Springer Nature Switzerland :  |b Imprint: Springer,  |c 2024. 
300 |a VIII, 426 p. 143 illus., 123 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1 - Heart physiology and heart diseases, Djordje Jakovljevic, Nenad Filipovic -- Chapter 2 - Finite element modeling, Nenad Filipovic -- Chapter 3 - System biology modeling for drug optimization, Marko Zivanovic, Nenad Filipovic -- Chapter 4 - Artificial intelligence approach for medical image processing, Tijana Sustersic, Nenad Filipovic.-Chapter 5 - Pharmacokinetic and AI modeling, Lazar Velicki, Nenad Filipovic -- Chapter 6 - Molecular micro modeling of heart muscle, Momcilo Prodanovic, Nenad Filipovic -- Chapter 7 - Use case: Risk stratification of cardiomyopathy disease, Lazar Dasic, Nenad Filipovic -- Chapter 8 - Use case: Surrogate AI model for left ventricle modeling, Bogdan Milicevic, Nenad Filipovic -- Chapter 9 - Use case: Carotid artery plaque modeling, Andjela Blagojevic, Nenad Filipovic -- Chapter 10 - Use case: Stent deployment for coronary artery, Miljan Milosevic, Nenad Filipovic -- Chapter 11 - Use case: Balloon deployment for peripheral arteries. Aleksandra Vulovic, Nenad Filipovic -- Chapter 12 - Use case: Aorta stenosis modeling, Smiljana Tomasevic, Nenad Filipovic -- Chapter 13 - Use case: Stent biodegradation modeling, Dalibor Nikolic, Nenad Filipovic. 
520 |a This book covers in silico clinical trials of cardiovascular disease using a finite element and machine learning approach. Part I describes the fundamentals as well as the latest developments in the field: finite element modeling, system biology modeling for drug optimization, artificial intelligence approach for medical image processing, as well as pharmacokinetic and AI modeling. Part II provides use cases to describe how in silico clinical trials of cardiovascular disease are applied to specific cardiovascular diseases: carotid artery plaque modeling, aorta stenosis modeling, stent biodegradation modeling, surrogate AI model for left ventricle modeling, and more. This book is geared toward upper-level undergraduate and graduate students as well as for researchers in the domains of bioengineering, biomechanics, biomedical engineering and medicine. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
650 0 |a Cardiovascular system. 
650 0 |a Physiology. 
650 0 |a Machine learning. 
650 0 |a Artificial intelligence. 
650 0 |a Drug delivery systems. 
650 1 4 |a Cardiovascular Physiology. 
650 2 4 |a Machine Learning. 
650 2 4 |a Artificial Intelligence. 
650 2 4 |a Drug Delivery. 
700 1 |a Filipović, Nenad.  |e editor.  |0 (orcid)0000-0001-9964-5615  |1 https://orcid.org/0000-0001-9964-5615  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031600432 
776 0 8 |i Printed edition:  |z 9783031600456 
776 0 8 |i Printed edition:  |z 9783031600463 
856 4 0 |u https://doi.org/10.1007/978-3-031-60044-9 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708) 

Ngā tūemi rite